Cincinnati Childrens Hospital — Cincinnati, Ohio

Public research footprint of Cincinnati Childrens Hospital, compiled from the ClinicalTrials.gov public registry.

118

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Migraine · Nephritis IgA Type, Nephropathy IgA Type · Major Depressive Disorder (MDD) · Pulmonary Arterial Hypertension

Recently updated registry entries

NCT05125302 — Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the… (Recruiting)
NCT05609630 — Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in… (Recruiting)
NCT05723198 — A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Cincinnati Childrens Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.